13.96
10 X Genomics Inc (TXG) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
11.64%
172.91
|
154.88 | 165.02 | 151.65 | 153.10 |
Cost Of Revenue |
3.26%
47.82
|
49.44 | 54.07 | 45.26 | 48.88 |
Gross Profit |
18.62%
125.08
|
105.44 | 110.95 | 106.39 | 104.22 |
|
34.41%
94.96
|
144.77 | 160.79 | 147.88 | 145.96 |
Benefits Costs and Expenses |
27.86%
135.91
|
188.39 | 213.40 | 186.09 | 190.18 |
Costs And Expenses |
27.86%
135.91
|
188.39 | 213.40 | 186.09 | 190.18 |
Operating Income/Loss |
176.60%
30.13
|
-39.33 | -49.84 | -41.48 | -41.74 |
Nonoperating Income/Loss |
18.02%
6.871
|
5.822 | 1.459 | 7.047 | 4.658 |
Income/Loss From Continuing Operations Before Tax |
210.42%
37.00
|
-33.51 | -48.38 | -34.44 | -37.08 |
Income Tax Expense/Benefit |
188.62%
2.459
|
0.852 | 0.648 | 1.315 | 0.818 |
Income/Loss From Continuing Operations After Tax |
200.52%
34.54
|
-34.36 | -49.03 | -35.75 | -37.90 |
|
200.52%
34.54
|
-34.36 | -49.03 | -35.75 | -37.90 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.94%
123.76
|
122.61 | 0.3844 | 120.73 | 120.07 |
Diluted Average Shares |
1.55%
124.51
|
122.61 | 0.3844 | 120.73 | 120.07 |
Basic Earnings Per Share |
200.00%
0.28
|
-0.28 | -0.41 | -0.30 | -0.32 |
Diluted Earnings Per Share |
200.00%
0.28
|
-0.28 | -0.41 | -0.30 | -0.32 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):